Achillion Pharmaceuticals Inc (NASDAQ:ACHN)

9.23
Delayed Data
As of May 22
 +0.12 / +1.32%
Today’s Change
2.65
Today|||52-Week Range
16.87
-24.65%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2011

2012

2013

2014
Revenue and IncomeNet Revenues247.0K2.6M0.000.00
 
 
 
Cost of Goods Sold3.1M--0.000.00
 
 
Depreciation And Amortization327.0K408.0K399.0K489.0K
 
 
 
 
 
 
Operating ExpensesGross Income-3.2M---399.0K-489.0K
 
 
 
 
General Expenses41.2M50.0M59.1M69.6M
 
 
 
 
 
Research And Development35.4M39.6M46.7M54.2M
 
 
 
 
 
Total Operating Expenses44.6M50.5M59.5M70.1M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-44.3M-47.8M-59.5M-70.1M
 
 
 
 
 
Interest Expense On Debt45.0K68.0K52.0K37.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-44.2M-47.7M-58.9M-69.7M
 
 
 
 
 
Income Taxes0.00-554.0K0.00-678.0K
 
 
 
Net Income-44.2M-47.1M-58.9M-69.0M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS64.2M74.0M94.0M98.4M
 
 
 
 
 
Shares To Calculate EPS Diluted64.2M74.0M94.0M98.4M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.69-$0.64-$0.63-$0.70
 
 
 
 
 
EPS Diluted-$0.69-$0.64-$0.63-$0.70
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account